SUNAKIMENT
UNII G5J5ELJ22V

Substance Identification & Data

This profile provides standardized clinical and technical data for Sunakiment, uniquely identified by the FDA Unique Ingredient Identifier (UNII) G5J5ELJ22V.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2928519-36-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

G5J5ELJ22V

CAS Registry Number

2928519-36-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

SUNAKIMENT

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C224792

National Cancer Institute reference terminology for clinical and research data.

INN ID

13581

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Sunakiment. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

SUNAKIMENT

Common Names & Synonyms

IMMUNOGLOBULIN FAB FRAGMENT, ANTI-(HUMAN THYMIC STROMAL LYMPHOPOIETIN) (HUMAN MONOCLONAL AZD8630 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL AZD8630 .LAMBDA.-CHAIN

IMMUNOGLOBULIN FAB VH-G1(CH1-7H)_L-LAMBDA2, ANTI-(HOMO SAPIENS TSLP (THYMIC STROMAL LYMPHOPOIETIN)), HOMO SAPIENS MONOCLONAL ANTIBODY (SUNAKIMENT)

SUNAKIMENT [INN]

VH-G1(CH1-7H) CHAIN ANTI-TSLP HOMO SAPIENS (H) (1-227) (VH (HOMO SAPIENS IGHV3-33*01 (93.9%) -(IGHD) -IGHJ3*02 (93.8%), CDR-IMGT (8.8.15) (26-33.51-58.97-111)) (1-122) - G1(CH1-7H) HOMO SAPIENS IGHG1*03, G1M3, CH1 R120 (CH1 R120 (219) (123-220), HINGE 1-7 (221-227)) (123-227)), (225-213')-DISULFIDE WITH L-LAMBDA2 LIGHT CHAIN ANTI-TSLP HOMO SAPIENS (L') (1'-214') (V-LAMBDA (HOMO SAPIENS IGLV3-21*02 (96.9%) -IGLJ2*01 (100%), CDR-IMGT (6.3.11) (26'-31'.49'-51'.88'-98')) (1'-108') -HOMO SAPIENS IGLC2*01 (100%) (C-LAMBDA2) (109'-214')), PRODUCED IN A CELL LINE FROM CHINESE HAMSTER OVARY (CHO) CELLS, DERIVED FROM THE CELL LINE CHO-K1, NON-GLYCOSYLATED

Technical Codes

AZD8630

AZD-8630

External Clinical & Regulatory Resources

Previous UNIIG5J54F79GO

Next UNIIG5J9B8L5TF